Australian National Enterovirus Reference Laboratory annual report, 2013
DOI:
https://doi.org/10.33321/cdi.2015.39.20Keywords:
poliovirus, acute flaccid paralysis, surveillance, enterovirus, poliomyelitis, eradication, vaccinationAbstract
Australia conducts surveillance for cases of acute flaccid paralysis (AFP) in children less than 15 years of age as the main method to monitor its polio-free status in accordance with the World Health Organization (WHO) recommendations. Cases of AFP in children are notified to the Australian Paediatric Surveillance Unit or the Paediatric Active Enhanced Disease Surveillance System and faecal specimens are referred for virological investigation to the National Enterovirus Reference Laboratory. In 2013, no cases of poliomyelitis were reported from clinical surveillance and Australia reported 1.4 non-polio AFP cases per 100,000 children, meeting the WHO performance criterion for a sensitive surveillance system. Non-polio enteroviruses can also be associated with AFP and enterovirus A71 was identified from nine of the 61 cases classified as non-polio AFP in 2013, which was part of a larger outbreak associated with this virus. A Sabin poliovirus was detected in an infant recently returned from Pakistan and who had been vaccinated while abroad. Globally, 416 cases of polio were reported in 2013, with the 3 endemic countries: Afghanistan; Nigeri;a and Pakistan, accounting for 38% of the cases. To safeguard the progress made towards polio eradication, in May 2014, WHO recommended travellers from the 10 countries that are currently reporting wild poliovirus transmission have documented evidence of recent polio vaccination before departure. Commun Dis Intell 2015;39(2):E208–E216.
Downloads
References
Study Protocol, Acute Flaccid Paralysis. Australian Paediatric Surveillance Unit [Online]. Accessed on 4 March 2014. Available from: http://www.apsu.org.au//assets/current-studies/AFP-Study-Protocol-APSU-Final-110810.pdf
Paediatric Active Enhanced Disease Surveillance. Australian Paediatric Surveillance Unit [Online]. Accessed on 4 March 2014. Available from: http://www.apsu.org.au/surveillance-systems/paeds/
Zurynski, Y, McIntyre P, Elliott, EJ. Paediatric active enhanced disease surveillance: a new surveillance system for Australia. J Paediatr Child H 2013;49(7):588–594.
Shulman LM, Gavrilin E, Jorba J, Martin J, Burns CC, Manor Y, et al. Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013. Euro Surveill. 2014;19(7):pii=20709.
Wild poliovirus 2009–2014. World Health Organization [Online]. Accessed on 12 June 2014. Available from: http://www.polioeradication.org/Portals/0/Document/Data&Monitoring/Wild_poliovirus_list_2009_2014_3Jun.pdf
IPV introduction, OPV withdrawal and routine immunization strengthening. World Health Organization [Online]. Accessed on 12 June 2014. Available from: http://www.who.int/immunization/diseases/poliomyelitis/inactivated_polio_vaccine/en/
WHO statement on the meeting of the International Health Regulations Emergency Committee concerning the international spread of wild poliovirus. World Health Organization [Online]. Accessed on 12 June 2014. Available from: http://www.who.int/mediacentre/news/statements/2014/polio-20140505/en/
Wood DJ, Hull B. L20B cells simplify culture of polioviruses from clinical samples. J Med Virol 1999;58(2):188–192.
World Health Organization. Polio Laboratory Manual, 4th edn. Department of Immunization, Vaccines and Biologicals 2004; WHO/IVB/04.10.
Kilpatrick DR, Yang CF, Ching K, Vincent A, Iber J, Campagnoli R, et al. Rapid group–, serotype–, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol 2009;47(6):1939–1941.
Stewardson AJ, Roberts JA, Beckett CL, Prime HT, Loh PS, Thorley BR, et al. An imported case of poliomyelitis in Melbourne, Australia. Emerg Infect Dis 2009;15(1):63–65.
Roberts JA, Thorley BR. Chapter 32: Enterovirus. In: Carter IWJ, Schuller M, James GS, Sloots TP, Halliday CL, eds. PCR for Clinical Microbiology, An Australian and International Perspective. 1st edn. Westmead; Springer: 2009.
Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol 2006;44(8):2698–2704.
Enhanced surveillance for enterovirus-associated neurological disease in children. New South Wales Government [Online]. Accessed on 12 June 2014. Available from: http://www.health.nsw.gov.au/Infectious/alerts/Documents/EV_Surv_Report_8_to_23June2013.pdf
Communicable disease control guidance and information: A–Z. Queensland Government [Online]. Accessed on 12 June 2014. Available from: http://www.health.qld.gov.au/cdcg/index/
Deverell M, Zurynski Y, Elliott E. Australian paediatric surveillance unit annual report 2012. Commun Dis Intell 2013;37(4):394–397.
Durrheim D. Remaining alert for polio importations. J Paediatr Child H 2014;50(4):329–330.
Enterovirus 71 (EV71) neurological disease. Victorian Government [Online]. Accessed on 12 June 2014. Available from: http://www.health.vic.gov.au/chiefhealthofficer/advisories/advisory-2013-05-enterovirus71.htm
Risk assessment of EV71 for the Western Pacific region. World Health Organization [Online]. Accessed 23 June 2010. This document was available from: www.wpro.who.int/sites/csr/data/RAEV71inWPR.htm
Human enterovirus 71—Australia: sub-genogroup C4a, acute flaccid paralysis. Archive number: 20130526.1738087. International Society for Infectious Diseases [Online]. Accessed on 12 June 2014. Available from: http://www.promedmail.org
Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010;10(11):778–790.
Liang ZL, Mao QY, Wang YP, Zhu FC, Li JX, Yao X, et al. Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccines Immunotherapeut 2013;9(8):1701–1705.
Zhu FC, Xu WB, Xia JL, Liang ZL, Liu Y, Zhang XF, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med 2014;370(9):818–828.
Li RC, Liu LD, Mo ZJ, Wang XY, Xia JL, Liang ZL, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med 2014;370(9):829–837.
Circulating vaccine-derived poliovirus cases, 2000–2014. World Health Organization [Online]. Accessed on 12 June 2014. Available from: http://www.polioeradication.org/Dataandmonitoring/Poliothisweek/Circulatingvaccinederivedpoliovirus.aspx
World Health Organization. Polio eradication and endgame strategic plan 2013–2018. Geneva; 2013.
Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. 10th edn. Canberra: Australian Government Department of Health; 2013.
Paterson BJ, Durrheim DN. Review of Australia’s polio surveillance. Commun Dis Intell 2013;37(2):E149–E155.
Poliomyelitis. Australian Government Department of Health [Online]. Accessed on 12 June 2014. Available from: http://www1.health.gov.au/internet/main/publishing.nsf/Content/ohp-poliomyelitis.htm
Downloads
Published
How to Cite
License
Copyright (c) 2015 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
